Our CEO Roman Grunt was very proud to be a guest speaker at the First International Forum on Innovation and Research of Drugs for Cancer event, and share how QUINTA-ANALYTICA manages it’s clinical trials. We were excited and pleased to accompany so many internationally renowned experts from academia and industry, including the fantastic other guest speakers to discuss the latest progress in cancer research. Thank you Atengen, Inc. for inviting us to join you in Tianjin, China!

Additional News

  • 16 December 2024

    Welcome, 2025!

    Reflecting on 2024 with gratitude and looking ahead with optimism.

  • 2 December 2024

    A Decade of Partnership with Adamed Pharma

    Adamed Pharma and Quinta-Analytica’s 10 – Year Journey in Pharma Innovation

  • 25 November 2024

    Expediting Biosimilar development: Streamlining the path from research to market

    On behalf of the Conscio Group, we would like to invite you to a free webinar on the future of the biosimilar pathway to approval, which is now open for registration.